Pharmanovia
Pharmanovia, a leading pharmaceutical company headquartered in Great Britain, has established itself as a key player in the global healthcare landscape since its founding in 2015. With a focus on specialty pharmaceuticals, the company operates across Europe, the Middle East, and Africa, delivering innovative solutions that address unmet medical needs.
Pharmanovia's core offerings include a diverse portfolio of products in therapeutic areas such as oncology, neurology, and rare diseases. What sets Pharmanovia apart is its commitment to enhancing patient access to high-quality medicines through strategic partnerships and a robust supply chain. The company has achieved notable milestones, including the successful launch of several proprietary products, solidifying its market position as a trusted provider in the pharmaceutical industry.
-15 vs industry average
Pharmanovia’s score of 23 is lower than 46% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Pharmanovia?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Pharmaceutical Preparation Manufacturing has below-average carbon intensity
Industry performance
The Pharmaceutical Preparation Manufacturing industry has reduced its overall emissions by 19% since 0
Emissions trajectory 2020 – 2026
Reported emissions
Scope 3 accounts for ••• of total emissions.
Pharmanovia's reported carbon emissions
In 2023, Pharmanovia reported total carbon emissions of approximately 15.8 million kg CO2e. This figure includes Scope 1 emissions of about 60,000 kg CO2e and Scope 3 emissions of approximately 4.5 million kg CO2e, with a significant portion attributed to purchased goods and services, which accounted for about 11.3 million kg CO2e. Notably, there is no reported data for Scope 2 emissions. Comparatively, in 2022, Pharmanovia's total emissions were approximately 12.5 million kg CO2e, with Scope 1 emissions remaining consistent at about 60,000 kg CO2e, while Scope 2 emissions were reported at approximately 3,000 kg CO2e. Scope 3 emissions for that year totalled around 3.2 million kg CO2e. Pharmanovia has not established specific reduction targets or initiatives as part of their climate commitments, and there are no cascading emissions data from a parent company. The organisation is focused on understanding and managing its carbon footprint, but further details on future commitments or strategies are not available at this time.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Pharmanovia’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Pharmanovia yet.
Scope 3 top emissions categories
2 of 15 categories disclosedSee all scope 3 categories
Already have an account? Sign in now
Emissions comparison with industry peers
View similar organisations
Pharmanovia
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project